↓ Skip to main content

Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP

Overview of attention for article published in Journal of Hematology & Oncology, April 2011
Altmetric Badge

Mentioned by

patent
2 patents

Citations

dimensions_citation
108 Dimensions

Readers on

mendeley
143 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Published in
Journal of Hematology & Oncology, April 2011
DOI 10.1186/1756-8722-4-16
Pubmed ID
Authors

Yuan Yuan, Yu-Min Liao, Chung-Tsen Hsueh, Hamid R Mirshahidi

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 3 2%
United Kingdom 2 1%
Belarus 1 <1%
Unknown 137 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 35 24%
Student > Ph. D. Student 23 16%
Student > Bachelor 15 10%
Student > Master 12 8%
Other 11 8%
Other 29 20%
Unknown 18 13%
Readers by discipline Count As %
Agricultural and Biological Sciences 44 31%
Medicine and Dentistry 41 29%
Biochemistry, Genetics and Molecular Biology 14 10%
Chemistry 8 6%
Immunology and Microbiology 3 2%
Other 11 8%
Unknown 22 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2016.
All research outputs
#7,523,962
of 22,961,203 outputs
Outputs from Journal of Hematology & Oncology
#507
of 1,194 outputs
Outputs of similar age
#40,251
of 109,810 outputs
Outputs of similar age from Journal of Hematology & Oncology
#3
of 5 outputs
Altmetric has tracked 22,961,203 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,194 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.0. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,810 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.